Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort
Authors:
Open Access
- 27 May 2015
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 67 (9) , 2369-2375
Abstract
Objective: To investigate the clinical course of disease over 2 years in patients with nonradiographic axial spondylarthritis (SpA) and patients with ankylosing spondylitis (AS).Methods: The study group comprised 303 patients with axial SpA (158 patients with AS and a symptom duration of ≤10 years and 145 patients with nonradiographic axial SpA and a symptom duration of ≤5 years) who did not receive tumor necrosis factor (TNF) blockers during 2 years of followup.Results: The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) did not differ between patients with nonradiographic axial SpA and those with AS at any time point during followup. The Bath Ankylosing Spondylitis Functional Index was significantly higher in patients with AS at baseline only, but spinal mobility was generally better in patients with nonradiographic SpA compared with those with AS. At all time points, C‐reactive protein (CRP) levels were significantly higher in patients with AS compared with patients with nonradiographic axial SpA. Accordingly, the Ankylosing Spondylitis Disease Activity Score (ASDAS) was significantly higher in the patients with AS at 2 of 4 time points. When patients with a BASDAI score of ≥4 plus an elevated CRP level at baseline were analyzed over time, there were no significant differences in the proportions of patients with nonradiographic axial SpA and those with AS who reached low disease activity status at ≥2 time points during 2 years of followup when a clinical definition of low disease activity was used (38% and 35%, respectively, achieved a BASDAI score of <4, and 13% and 15%, respectively, achieved a score of ≤2). When definitions that included the CRP level were used, however, a greater percentage of patients with nonradiographic axial SpA achieved low disease activity (25% of patients with nonradiographic axial SpA and 10% of patients with AS achieved a BASDAI score of <4 and a normal CRP level, and 13% of patients with nonradiographic axial SpA and 3% of those with AS achieved ASDAS‐defined low disease activity).Conclusion: Patients with nonradiographic axial SpA and those with AS who were not treated with TNF blockers demonstrated a similar clinical disease course over 2 years. Patients with nonradiographic axial SpA achieved a status of low disease activity more frequently than those with AS if outcome parameters that included the CRP level were used.Keywords
Funding Information
- The German Spondyloarthritis Inception Cohort (GESPIC)
- German Federal Ministry of Education and Research (BMBF) (FKZ 01G19946)
- German Competence Network in Rheumatology
- BMBF
- Abbott
- Amgen
- Centocor
- Schering-Plough
- Wyeth
- GESPIC
- AbbVie
- ANCYLOSS project (FZK 01EC1002D)
- ArthroMark project (FKZ 01EC1009A, FKZ 01EC1401A)
- METARTHROS project (FKZ 01EC1407A)
This publication has 14 references indexed in Scilit:
- The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and ConcernsArthritis & Rheumatology, 2014
- Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 studyAnnals of the Rheumatic Diseases, 2014
- Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational CohortArthritis & Rheumatism, 2013
- Prevalence of Axial Spondyloarthritis in United States Rheumatology Practices: Assessment of SpondyloArthritis International Society Criteria Versus Rheumatology Expert Clinical DiagnosisArthritis Care & Research, 2013
- Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trialAnnals of the Rheumatic Diseases, 2013
- Review: Nonradiographic axial spondyloarthritis: New definition of an old disease?Arthritis & Rheumatism, 2013
- Do patients with non‐radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?Arthritis Care & Research, 2012
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selectionAnnals of the Rheumatic Diseases, 2009
- The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohortArthritis & Rheumatism, 2009
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984